Precision BioSciences Q1 EPS $1.70 Beats $(1.91) Estimate, Sales $17.58M Beat $6.02M Estimate
Precision BioSciences Q1 EPS $1.70 Beats $(1.91) Estimate, Sales $17.58M Beat $6.02M Estimate
Precision BioSciences第一季度每股收益1.70美元，超过预期（1.91美元），销售额1758万美元超过602万美元的预期
Precision BioSciences (NASDAQ:DTIL) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $(1.91) by 189.01 percent. This is a 124.64 percent increase over losses of $(6.90) per share from the same period last year. The company reported quarterly sales of $17.58 million which beat the analyst consensus estimate of $6.02 million by 192.09 percent. This is a 100.27 percent increase over sales of $8.78 million the same period last year.
Precision BioSciences（纳斯达克股票代码：DTIL）公布的季度收益为每股1.70美元，比分析师普遍预期的1.91美元（1.91美元）高出189.01％。与去年同期每股亏损6.90美元（6.90）相比，增长了124.64％。该公司公布的季度销售额为1758万美元，比分析师普遍预期的602万美元高出192.09％。这比去年同期的878万美元的销售额增长了100.27％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。